Cancer and Systemic Lupus Erythematosus.
Cancer
Epidemiology
Malignancy
Systemic lupus erythematosus
Journal
Rheumatic diseases clinics of North America
ISSN: 1558-3163
Titre abrégé: Rheum Dis Clin North Am
Pays: United States
ID NLM: 8708093
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
entrez:
8
7
2020
pubmed:
8
7
2020
medline:
26
8
2021
Statut:
ppublish
Résumé
Systemic lupus erythematosus is associated with a small overall increased cancer risk compared with the general population. This risk includes a 4-fold increased risk of non-Hodgkin lymphoma, but a decreased risk of other cancers (such as breast cancer). The pathophysiology underlying the increased risk of hematologic cancer is not fully understood, but many potential mechanisms have been proposed, including dysfunction of the tumor necrosis factor and other pathways. A decreased risk of breast, ovarian, and endometrial cancer might be driven by hormonal factors or lupus-related antibodies, but these links have not been proved.
Identifiants
pubmed: 32631602
pii: S0889-857X(20)30057-0
doi: 10.1016/j.rdc.2020.05.005
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
533-550Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure None.